4528 N Stock Overview
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Ono Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥341.69 |
| 52 Week High | JP¥341.69 |
| 52 Week Low | JP¥341.69 |
| Beta | 0.20 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -34.46% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -29.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4528 N | MX Pharmaceuticals | MX Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | -0.9% |
| 1Y | -34.5% | -20.7% | -4.7% |
Return vs Industry: 4528 N underperformed the MX Pharmaceuticals industry which returned -18.9% over the past year.
Return vs Market: 4528 N underperformed the MX Market which returned 1.8% over the past year.
Price Volatility
| 4528 N volatility | |
|---|---|
| 4528 N Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in MX Market | 6.1% |
| 10% least volatile stocks in MX Market | 2.6% |
Stable Share Price: 4528 N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 4528 N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1717 | 3,761 | Gyo Sagara | www.ono-pharma.com |
Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia. The company also provides Glactiv tablets for type 2 diabetes; Forxiga tablets for diabetes; Onoact Intravenous Infusion for tachyarrhythmia; Opalmon tablets to treat peripheral circulatory disorder; Coralan for chronic heart failure; Orencia injections for rheumatoid arthritis; Rivastach patches for Alzheimer’s disease; Ongentys tablets for Parkinson’s disease; Parsabiv, an intravenous infusion for dialysis patients; Staybla tablets for overactive bladder; Onon capsules and Dry Syrups for bronchial asthma and allergic rhinitis; and JOYCLU intra-articular injection for the improvement of joint function, as well as Recalbon tablets for osteoporosis.
Ono Pharmaceutical Co., Ltd. Fundamentals Summary
| 4528 N fundamental statistics | |
|---|---|
| Market cap | Mex$148.29b |
| Earnings (TTM) | Mex$14.53b |
| Revenue (TTM) | Mex$56.93b |
10.2x
P/E Ratio2.6x
P/S RatioIs 4528 N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4528 N income statement (TTM) | |
|---|---|
| Revenue | JP¥489.20b |
| Cost of Revenue | JP¥121.12b |
| Gross Profit | JP¥368.08b |
| Other Expenses | JP¥243.21b |
| Earnings | JP¥124.88b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Jan 31, 2024
| Earnings per share (EPS) | 260.99 |
| Gross Margin | 75.24% |
| Net Profit Margin | 25.53% |
| Debt/Equity Ratio | 0% |
How did 4528 N perform over the long term?
See historical performance and comparisonDividends
3.0%
Current Dividend Yield30%
Payout RatioDoes 4528 N pay a reliable dividends?
See 4528 N dividend history and benchmarks| Ono Pharmaceutical dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2024 |
| Dividend Pay Date | Jun 24 2024 |
| Days until Ex dividend | 240 days |
| Days until Dividend pay date | 152 days |
Does 4528 N pay a reliable dividends?
See 4528 N dividend history and benchmarks